Restart Life Sciences Corp. (NMLSF)
OTCMKTS · Delayed Price · Currency is USD
0.0822
0.00 (0.00%)
Feb 10, 2026, 9:30 AM EST
Restart Life Sciences Market Cap
Restart Life Sciences has a market cap or net worth of $4.19 million as of February 12, 2026. Its market cap has increased by 158.18% in one year.
Market Cap
4.19M
Enterprise Value
4.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since September 22, 2006, Restart Life Sciences's market cap has increased from 3.94M to 4.19M, an increase of 6.33%. That is a compound annual growth rate of 0.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 4.19M | -13.09% |
| Dec 31, 2025 | 4.82M | 542.37% |
| Dec 31, 2024 | 751.10K | -66.30% |
| Dec 29, 2023 | 2.23M | -78.98% |
| Dec 30, 2022 | 10.60M | 118.83% |
| Dec 31, 2021 | 4.85M | -74.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 6.46M |
| GPL Holdings | 5.83M |
| Bioxytran | 5.56M |
| LakeShore Biopharma | 5.33M |
| Enzon Pharmaceuticals | 5.33M |
| Clearside Biomedical | 5.10M |
| AXIM Biotechnologies | 4.63M |
| Nymox Pharmaceutical | 4.23M |